Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center


Learn More

VICC toll-free number 1-877-936-8422

Clinical Trial VICCTHN1292


Validation of Molecular Biomarkers for the Early Detection of Lung Cancer in the Setting of Indeterminate Pulmonary Nodules (Lung Team Project #2)

Principal Investigator(s)

Pierre Massion


  • Protocol No. VICCTHN1292
  • Open Date: 03/18/2013
  • Staging: N/A
  • Age Group: Adults
  • Scope: National
  • Objective: - Establish a cohort (n=200) of current and former smokers with indeterminate pulmonary nodules (7mm-20mm) on whom clinical, radiographic and biospecimen repositories are developed and who are followed prospectively until final diagnosis. - Validate the diagnostic accuracy of existing molecular biomarkers in the airway and blood to detect lung cancer in this clinical cohort.
  • Disease Sites: Lung
  • Therapies: None Specified
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University
  • Secondary Protocol No: Not Specified


None Provided.


Not provided. Please call for more information.